SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+6.94%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.32B
AUM Growth
+$1.32B
(-7%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$33.4M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$25.4M |
| 3 |
Alignment Healthcare
ALHC
|
$23.1M |
| 4 |
Vor Biopharma
VOR
|
$23.1M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$21.9M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$38.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$35M |
| 3 |
Labcorp
LH
|
$31.5M |
| 4 |
Exelixis
EXEL
|
$29.6M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Align Technology
ALGN
$9.59B
| $18M | 1.36% |
33,225
-12,925
| -28% | -$7M |
|
27
Amicus Therapeutics
FOLD
$2.42B
| $17.5M | 1.32% |
1,766,704
+232,100
| +15% | +$2.29M |
|
28
Agilent Technologies
A
$35.5B
| $15.8M | 1.2% |
+124,000
| New | +$15.8M |
|
29
Alnylam Pharmaceuticals
ALNY
$58.6B
| $15.5M | 1.17% |
109,746
+1,400
| +1% | +$198K |
|
|
OLK
30
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $15.3M | 1.16% |
+425,198
| New | +$15.3M |
|
31
ResMed
RMD
$39.4B
| $14.8M | 1.12% |
76,105
+9,800
| +15% | +$1.9M |
|
32
Quanterix
QTRX
$202M
| $14.2M | 1.08% |
+243,689
| New | +$14.2M |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.5M | 1.03% |
79,081
+5,443
| +7% | +$932K |
|
34
Cooper Companies
COO
$13.3B
| $13.3M | 1.01% |
+34,700
| New | +$13.3M |
|
|
HARP
35
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $13.2M | 1% |
+631,050
| New | +$13.2M |
|
|
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.1M | 0.99% |
142,475
+133,000
| +1,404% | +$12.2M |
|
37
Natera
NTRA
$23B
| $13.1M | 0.99% |
128,850
+40,900
| +47% | +$4.15M |
|
38
Ultragenyx Pharmaceutical
RARE
$3.04B
| $12.8M | 0.97% |
+112,200
| New | +$12.8M |
|
39
Insmed
INSM
$30.3B
| $12.6M | 0.96% |
+370,200
| New | +$12.6M |
|
40
Centene
CNC
$14.8B
| $12.6M | 0.96% |
197,275
-59,240
| -23% | -$3.79M |
|
41
Inspire Medical Systems
INSP
$2.53B
| $12.5M | 0.95% |
+60,500
| New | +$12.5M |
|
42
InnovAge Holding
INNV
$509M
| $12.4M | 0.94% |
+479,794
| New | +$12.4M |
|
43
Insulet
PODD
$24.2B
| $12.4M | 0.94% |
47,354
+4,700
| +11% | +$1.23M |
|
44
Hologic
HOLX
$14.7B
| $12.1M | 0.92% |
162,800
+4,500
| +3% | +$335K |
|
45
Johnson & Johnson
JNJ
$429B
| $11.9M | 0.9% |
72,500
-2,000
| -3% | -$329K |
|
46
Fate Therapeutics
FATE
$115M
| $11.7M | 0.89% |
142,500
+43,500
| +44% | +$3.59M |
|
|
ALXN
47
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.7M | 0.88% |
76,226
-11,750
| -13% | -$1.8M |
|
48
DexCom
DXCM
$30.9B
| $11.5M | 0.87% |
31,913
-10,550
| -25% | -$3.79M |
|
49
BridgeBio Pharma
BBIO
$9.91B
| $11.3M | 0.86% |
183,100
+177,100
| +2,952% | +$10.9M |
|
|
PRAH
50
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.2M | 0.85% |
73,200
-63,570
| -46% | -$9.75M |
|